Novartis Expects Steady Sales Growth Through 2030

Core Insights - The pharmaceutical giant is optimistic about its future, indicating strong positioning beyond the next decade due to increased expectations for its key drugs [1] Summary by Categories - Company Outlook - The company expresses confidence in its long-term prospects, suggesting that it is well-prepared for growth beyond the next ten years [1] - Key Drug Performance - There is an emphasis on higher expectations for the company's key drugs, which are expected to drive future revenue and growth [1]